Study of Use of Dexmedetomidine for Regional Anesthesia
Status:
Withdrawn
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the proper amount of a drug called dexmedetomidine
added to the local anesthetic drug called lidocaine to prolong the time and effect of pain
relief provided for surgery.
Dexmedetomidine (trade name Precedex) is approved by U.S. Food and Drug Administration (FDA)
and indicated for sedation (calming effect). It has both pain relieving and calming effects
when added to lidocaine. In the past, addition of higher amounts of dexmedetomidine to
lidocaine decreased blood pressure and heart rate. The investigators plan to study the effect
of lower amounts of dexmedetomidine to achieve the same level and duration of pain relief
without reduction of blood pressure and heart rate.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health